PROCEPT BIOROBOTICS CORPORATION PROCEPT BioRobotics Corporation
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.1 USD | -0.06% |
|
+8.70% | +62.49% |
Presentation Operator MessageOperator (Operator)Good day, and welcome to PROCEPT BioRobotics T...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Companyâs proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
68.1
USD
Average target price
70.83
USD
Spread / Average Target
+4.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +62.49% | 3.5B | |
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +7.52% | 42.73B | |
| +25.54% | 32.52B | |
| +17.85% | 26.02B | |
| +1.00% | 25.91B |
- Stock Market
- Equities
- PRCT Stock
- News PROCEPT BioRobotics Corporation
- Transcript : PROCEPT BioRobotics Corporation, Q3 2023 Earnings Call, Nov 01, 2023
